Characterizing the outcomes of metastatic papillary renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterizing the outcomes of metastatic papillary renal cell carcinoma

Published:2017-04-16 Issue:5 Volume:6 Page:902-909
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Connor Wells John¹²^ORCID,Donskov Frede³,Fraccon Anna P.⁴,Pasini Felice⁵,Bjarnason Georg A.⁶,Beuselinck Benoit⁷,Knox Jennifer J.⁸,Rha Sun Young⁹,Agarwal Neeraj¹⁰,Bowman Isaac Alex¹¹,Lee Jae-Lyun¹²,Pal Sumanta K.¹³,Srinivas Sandy¹⁴,Scott Ernst Douglas¹⁵,Vaishampayan Ulka N.¹⁶,Wood Lori A.¹⁷,Simpson Robin¹⁷,De Velasco Guillermo¹⁸,Choueiri Toni K.¹⁸,Heng Daniel Y. C.¹

Affiliation:

1. Tom Baker Cancer Centre; University of Calgary; Calgary Alberta Canada

2. Queen's University; Kingston Ontario Canada

3. Aarhus University Hospital; Aarhus Denmark

4. Casa di Cura Pederzoli; Peschiera Del Garda Italy

5. Medical Oncology Department; Ospedale Santa Maria della Misericordia; Rovigo Italy

6. Sunnybrook Odette Cancer Centre; Toronto Ontario Canada

7. University Hospitals Leuven; Leuven Belgium

8. Princess Margaret Hospital; Toronto Ontario Canada

9. Yonsei University College of Medicine; Seoul South Korea

10. Huntsman Cancer Institute; University of Utah; Salt Lake City Utah

11. University of Texas Southwestern Medical Center; Dallas Texas

12. Asan Medical Centre; University of Ulsan College of Medicine; Seoul South Korea

13. City of Hope Comprehensive Cancer Center; Duarte California

14. Stanford Cancer Center; Stanford California

15. London Health Sciences Center; London Ontario Canada

16. Karmanos Cancer Institute; Detroit Michigan

17. Queen Elizabeth II Health Sciences Centre; Halifax Nova Scotia Canada

18. Dana Farber Cancer Institute; Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference32 articles.

1. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience;Patard;J. Clin. Oncol.,2004

2. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma;Beck;Ann. Surg. Oncol.,2004

3. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity;Shuch;Eur. Urol.,2015

4. Comprehensive molecular characterization of papillary renal-cell carcinoma;The Cancer Genome Atlas Research Network;N. Engl. J. Med.,2016

5. MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array;Albiges;Clin. Cancer Res.,2014

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pan-cancer analysis of EphA family gene expression and its association with prognosis, tumor microenvironment, and therapeutic targets;Frontiers in Oncology;2024-06-17

2. Locoregional Therapies in Immunologically “Cold” Tumors: Opportunities and Clinical Trial Design Considerations;Journal of Vascular and Interventional Radiology;2024-02

3. Bioinformatics Analysis Highlights GABRD as a Potential Prognostic Biomarker and Therapeutic Target in Kidney Renal Papillary Cell Carcinoma;2024

4. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma;BMC Urology;2023-04-01

5. Divulging a Pleiotropic Role of Succinate Receptor SUCNR1 in Renal Cell Carcinoma Microenvironment;Cancers;2022-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3